Catheter Precision Corporation - רווח נקי למניה אחת בשנים עשר החודשים האחרונים VTAK

The financial stability of Catheter Precision (VTAK) is limited by its dependence on external assembly contractors. The 12-month YoY EPS trend illustrates this volatility, where the current parameter equals 91.00. Meanwhile, proprietary equipment ensures high production margins. Business growth relies on the organic implementation of heart mapping systems in clinics without the use of merger deals.

Assessing the asset quality of Catheter Precision (VTAK) requires an analysis of earnings per share dynamics. By examining the YoY ttm net income per share growth rate chart, an investor can see the percentage change in EPS over twelve months. For this developer of cardiac surgery navigation systems, this metric reflects the monetization efficiency of high-precision IT technologies. Growth in this metric confirms the scalability of the business. However, extrapolating data without accounting for the weighted average cost of capital (WACC) creates the risk of overpaying for the asset.